346 related articles for article (PubMed ID: 24251801)
1. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.
Liu LX; Li-Li J; Qiong C; Xiao-Lin F
Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Antischistosomal Drugs and Agents.
Liu L; Li-Li J; Qiong C; Xiao-Lin F
Mini Rev Med Chem; 2016 Jun; ():. PubMed ID: 27364000
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Antischistosomal Drugs and Agents.
Liang-Xian L; Fan CQ; Xiao-Lin
Mini Rev Med Chem; 2013 Jan; ():. PubMed ID: 23373655
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for Fighting Schistosomiasis: Past, Present and Future.
Mäder P; Rennar GA; Ventura AMP; Grevelding CG; Schlitzer M
ChemMedChem; 2018 Nov; 13(22):2374-2389. PubMed ID: 30212614
[TBL] [Abstract][Full Text] [Related]
5. Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine.
da Silva VBR; Campos BRKL; de Oliveira JF; Decout JL; do Carmo Alves de Lima M
Bioorg Med Chem; 2017 Jul; 25(13):3259-3277. PubMed ID: 28495384
[TBL] [Abstract][Full Text] [Related]
6. Schistosomiasis control: praziquantel forever?
Cioli D; Pica-Mattoccia L; Basso A; Guidi A
Mol Biochem Parasitol; 2014 Jun; 195(1):23-9. PubMed ID: 24955523
[TBL] [Abstract][Full Text] [Related]
7. The potential of artemether for the control of schistosomiasis.
Utzinger J; Xiao S; N'Goran EK; Bergquist R; Tanner M
Int J Parasitol; 2001 Dec; 31(14):1549-62. PubMed ID: 11730781
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species.
Xiao SH; Keiser J; Chollet J; Utzinger J; Dong Y; Endriss Y; Vennerstrom JL; Tanner M
Antimicrob Agents Chemother; 2007 Apr; 51(4):1440-5. PubMed ID: 17283188
[TBL] [Abstract][Full Text] [Related]
9. Antischistosomal Properties of Hederacolchiside A1 Isolated from
Kang N; Shen W; Gao H; Feng Y; Zhu W; Yang S; Liu Y; Xu Q; Yu D
Molecules; 2018 Jun; 23(6):. PubMed ID: 29899232
[No Abstract] [Full Text] [Related]
10. Molecular basis for hycanthone drug action in schistosome parasites.
Guzman M; Rugel A; Tarpley RS; Cao X; McHardy SF; LoVerde PT; Taylor AB
Mol Biochem Parasitol; 2020 Mar; 236():111257. PubMed ID: 32027942
[TBL] [Abstract][Full Text] [Related]
11. [Histone deacetylase and histone acetyltransferase inhibitors as antischistosomal agents: a review].
Wang Y; Xu J; Xia C
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Mar; 36(2):207-214. PubMed ID: 38857968
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological and immunological effects of praziquantel against Schistosoma japonicum: a scoping review of experimental studies.
Xiao SH; Sun J; Chen MG
Infect Dis Poverty; 2018 Feb; 7(1):9. PubMed ID: 29409536
[TBL] [Abstract][Full Text] [Related]
13. Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use.
Abdul-Ghani RA; Loutfy N; Hassan A
Parasitol Res; 2009 Oct; 105(4):899-906. PubMed ID: 19588166
[TBL] [Abstract][Full Text] [Related]
14. Schistosomiasis: Drugs used and treatment strategies.
Siqueira LDP; Fontes DAF; Aguilera CSB; Timóteo TRR; Ângelos MA; Silva LCPBB; de Melo CG; Rolim LA; da Silva RMF; Neto PJR
Acta Trop; 2017 Dec; 176():179-187. PubMed ID: 28803725
[TBL] [Abstract][Full Text] [Related]
15. Toward organometallic antischistosomal drug candidates.
Hess J; Keiser J; Gasser G
Future Med Chem; 2015; 7(6):821-30. PubMed ID: 25996072
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antischistosomal activity of linker- and thiophene-modified biaryl alkyl carboxylic acid derivatives.
Peter Ventura AM; Haeberlein S; Konopka L; Obermann W; Grünweller A; Grevelding CG; Schlitzer M
Arch Pharm (Weinheim); 2021 Dec; 354(12):e2100259. PubMed ID: 34523746
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of new praziquantel analogues: potential candidates for the treatment of schistosomiasis.
Sadhu PS; Kumar SN; Chandrasekharam M; Pica-Mattoccia L; Cioli D; Rao VJ
Bioorg Med Chem Lett; 2012 Jan; 22(2):1103-6. PubMed ID: 22217873
[TBL] [Abstract][Full Text] [Related]
18. Small change, big difference: A promising praziquantel derivative designated P96 with broad-spectrum antischistosomal activity for chemotherapy of schistosomiasis japonica.
Xu J; Dong LL; Sun H; Huang P; Zhang RZ; Wang XY; Sun DQ; Xia CM
PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011215. PubMed ID: 37410790
[TBL] [Abstract][Full Text] [Related]
19. Praziquantel derivatives exhibit activity against both juvenile and adult Schistosoma japonicum.
Duan WW; Qiu SJ; Zhao Y; Sun H; Qiao C; Xia CM
Bioorg Med Chem Lett; 2012 Feb; 22(4):1587-90. PubMed ID: 22264473
[TBL] [Abstract][Full Text] [Related]
20. Antischistosomal activity of artemisinin derivatives in vivo and in patients.
Saeed MEM; Krishna S; Greten HJ; Kremsner PG; Efferth T
Pharmacol Res; 2016 Aug; 110():216-226. PubMed ID: 26902577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
